Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
67,953
Sort by:
Coronary Intervention Device Market in China 2021
US$ 450.00
The coronary intervention device market in China in terms of revenue is set to grow by US$ 1 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 9.2% during the forecast perio...
March 2021
39 pages
Decitabine Market in China 2021
US$ 450.00
The decitabine market in China in terms of revenue is set to grow by US$ 665 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 22.5% during the forecast period, according to...
March 2021
21 pages
Digital Health and Wellness Market in China 2021
US$ 450.00
The digital health and wellness market in China in terms of revenue is set to grow by US$ 199 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 30.7% during the forecast per...
March 2021
25 pages
Edaravone Pharmaceutical Market in China 2021
US$ 450.00
The edaravone pharmaceutical market in China in terms of revenue is expected to decline at a compound annual growth rate (CAGR) of -0.8% from US$ 426 million in 2020 to 429 million in 2027, according...
March 2021
21 pages
Embolization Coil Market in China 2021
US$ 450.00
The embolization coil market in China in terms of revenue is set to grow by US$ 233 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 11.3% during the forecast period, accor...
March 2021
21 pages
Enoxaparin Finished Dose Market in China 2021
US$ 450.00
The enoxaparin finished dose market in China in terms of revenue is set to grow by US$ 968 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 23.6% during the forecast period...
March 2021
24 pages
Environmental Hygiene Services Market in China 2021
US$ 450.00
The environmental hygiene services market in China in terms of revenue is set to grow by US$ 70 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 14.5% during the forecast p...
March 2021
21 pages
Gastric Cancer Drug Market in China 2021
US$ 450.00
The gastric cancer drug market in China in terms of revenue is set to grow by US$ 4 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 10.3% during the forecast period, accor...
March 2021
24 pages
Gemcitabine Hydrochloride Drugs Market in China 2021
US$ 450.00
The gemcitabine hydrochloride drugs market in China in terms of revenue is set to grow by US$ 281 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 11.4% during the forecast...
March 2021
25 pages
Global Enoxaparin Finished Dose Market 2021
US$ 450.00
The global enoxaparin finished dose market in terms of revenue is set to grow by US$ 1 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 5.9% during the forecast period, acc...
March 2021
21 pages
Global Heparin API Market 2021
US$ 450.00
The global heparin API market in terms of revenue is set to grow by US$ 1 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period, according to dat...
March 2021
40 pages
Global Heparin Finished Dose Market 2021
US$ 450.00
The global heparin finished dose market in terms of revenue is set to grow by US$ 2 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 5.3% during the forecast period, accord...
March 2021
24 pages
Global Prostate Cancer Drug Market 2021
US$ 450.00
The global prostate cancer drug market in terms of revenue is set to grow by US$ 11 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 10.5% during the forecast period, accor...
March 2021
24 pages
Health and Wellness Market in China 2021
US$ 450.00
The health and wellness market in China in terms of revenue is set to grow by US$ 1,044 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 9.4% during the forecast period, ac...
March 2021
23 pages
Hepatocellular Carcinoma (HCC) Drug Market in China 2021
US$ 450.00
The hepatocellular carcinoma (HCC) drug market in China in terms of revenue is set to grow by US$ 4 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 21.7% during the foreca...
March 2021
21 pages
Iimatinib Mesylate Market in China 2021
US$ 450.00
The iImatinib mesylate market in China in terms of revenue is set to grow by US$ 2 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 22.9% during the forecast period, accord...
March 2021
24 pages
Immunoassay IVD (In Vitro Diagnostic) Market in China 2021
US$ 450.00
The immunoassay IVD (in vitro diagnostic) market in China in terms of revenue is set to grow by US$ 12 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 20.1% during the for...
March 2021
24 pages
ITP (Immune Thrombocytopenia) Drug Market in China 2021
US$ 450.00
The ITP (immune thrombocytopenia) drug market in China in terms of revenue is set to grow by US$ 714 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 25.3% during the forec...
March 2021
24 pages
IVD (In Vitro Diagnostic) Market in China 2021
US$ 450.00
The IVD (in vitro diagnostic) market in China in terms of revenue is set to grow by US$ 26 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 19.4% during the forecast period...
March 2021
22 pages
Lipid-Lowering Drugs Market in China 2021
US$ 450.00
The lipid-lowering drugs market in China in terms of revenue is set to grow by US$ 5 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 11.4% during the forecast period, acco...
March 2021
21 pages
Mechanical Thrombectomy Device Market in China 2021
US$ 450.00
In terms of revenue, the mechanical thrombectomy device market in China is projected to grow at a compound annual growth rate (CAGR) of 25.8% over the analysis period of 2021 to 2027, according to dat...
March 2021
23 pages
Methyl Iodide Market in China 2021
US$ 450.00
In terms of volume, the methyl iodide market in China is expected to grow at a compound annual growth rate (CAGR) of 5.1% over the analysis period of 2021 to 2027, according to data and analytics comp...
March 2021
22 pages
MG (Myasthenia Gravis) Drug Market in China 2021
US$ 450.00
The MG (myasthenia gravis) drug market in China in terms of revenue is set to grow by US$ 565 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 51% during the forecast perio...
March 2021
22 pages
Microsphere Agents Market in China 2021
US$ 450.00
The microsphere agents market in China in terms of revenue is set to grow by US$ 1 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 17.3% during the forecast period, accord...
March 2021
21 pages
Moderate and Severe Dry Eye Disease Market in China 2021
US$ 450.00
The moderate and severe dry eye disease market in China in terms of revenue is set to grow by US$ 570 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 30.4% during the fore...
March 2021
25 pages
Moxifloxacin Market in China 2021
US$ 450.00
The moxifloxacin market in China in terms of revenue is set to grow by US$ 554 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 9.1% during the forecast period, according t...
March 2021
21 pages
Multiple Myeloma Drug Market in China 2021
US$ 450.00
The multiple myeloma drug market in China in terms of revenue is set to grow by US$ 2 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 18.8% during the forecast period, acc...
March 2021
21 pages
Myelodysplastic Syndromes (MDS) Drug Market in China 2021
US$ 450.00
The myelodysplastic syndromes (MDS) drug market in China in terms of revenue is set to grow by US$ 548 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 17.3% during the for...
March 2021
22 pages
Olanzapine Drugs Market in China 2021
US$ 450.00
The olanzapine drugs market in China in terms of revenue is set to grow by US$ 503 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 11.7% during the forecast period, accord...
March 2021
24 pages
Oncology Drug Market in China 2021
US$ 450.00
The oncology drug market in China in terms of revenue is set to grow by US$ 42 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 13.8% during the forecast period, according...
March 2021
40 pages
Online Retail Pharmacy Market in China 2021
US$ 450.00
The online retail pharmacy market in China in terms of revenue is set to grow by US$ 146 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 33.3% during the forecast period,...
March 2021
24 pages
Ophthalmic Drug Market in China 2021
US$ 450.00
The ophthalmic drug market in China in terms of revenue is set to grow by US$ 6 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 17.9% during the forecast period, according...
March 2021
25 pages
Pemetrexed Pharmaceutical Market in China 2021
US$ 450.00
The pemetrexed pharmaceutical market in China in terms of revenue is set to grow by US$ 443 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 10.1% during the forecast perio...
March 2021
24 pages
Pharmaceutical R&D Expenditure Market in China 2021
US$ 450.00
The pharmaceutical R&D expenditure market in China in terms of revenue is set to grow by US$ 34 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 16.8% during the forecast p...
March 2021
21 pages
Prostate Cancer Drug Market in China 2021
US$ 450.00
The prostate cancer drug market in China in terms of revenue is set to grow by US$ 3 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 27.7% during the forecast period, acco...
March 2021
21 pages
Pulmonary Arterial Hypertension (PAH) Market in China 2021
US$ 450.00
The pulmonary arterial hypertension (PAH) market in China in terms of revenue is set to grow by US$ 787 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 49.6% during the fo...
March 2021
22 pages
Rabeprazole Market in China 2021
US$ 450.00
The rabeprazole market in China in terms of revenue is set to grow by US$ 860 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 12.7% during the forecast period, according t...
March 2021
25 pages
